$93.16
Value $62.3B
CRH and RECT stock compared: price, dividend, valuation and results, from SEC filings.
$93.16
Value $62.3B
$1.29
Value $19M
CRH (CRH) has a market value of $62.3B and Rectitude (RECT) $19M. Over the last year, with dividends, CRH moved -16.6% and RECT -35.6%. The P/E is 17.5 for CRH and 6.7 for RECT. Dividend yield: CRH 1.67%, RECT none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CRH$62.3B
RECT$19M
CRH is 3,328 times RECT
Revenue, 12 months
CRH$39.0B
RECT$40M
CRH is 980 times RECT
Net income, 12 months
CRH$3.6B
RECT$2.8M
CRH is 1,285 times RECT
Operating margin
CRH13.7%
RECT8.3%
5.4 points apart
ROIC
CRH9.2%
RECT10.4%
1.2 points apart
P/E
CRH17.5
RECT6.7
CRH is 2.6 times RECT
Dividend yield
CRH1.7%
RECT0.0%
1.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CRH-16.6%
RECT-35.6%
| Period | CRHWith dividends | RECTWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | -16.6%Price -17.8% | -35.6%Price -40.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
CRHCRHRECTRectitude
| Price | $93.16 | $1.29 |
|---|---|---|
| Market value | $62.3B | $19M |
| Enterprise value (EV) | $77.4B | $18M |
| P/E | 17.5 | 6.7 |
| P/E, 5-year median | 16.0 | – |
| P/B | 2.5 | 0.9 |
| EV/EBIT | 14.5 | 5.5 |
| Free cash flow yield | 4.1% | – |
| Revenue, 12 months | $39.0B | $40M |
|---|---|---|
| Net income, 12 months | $3.6B | $2.8M |
| Free cash flow, 12 months | $2.5B | -$1.8M |
| Earnings per share, 12 months | $5.32 | $0.19 |
| Revenue growth, year on year | 5.3% | 17.1% |
| Revenue growth a year, past | +7.7%over 5 years | +14.5%over 4 years |
| EPS growth a year, past | -47.8%over 5 years | +10.1%over 4 years |
| Gross margin | 36.2% | 32.2% |
|---|---|---|
| Operating margin | 13.7% | 8.3% |
| Net margin | 9.2% | 7.0% |
| ROIC | 9.2% | 10.4% |
| ROE | 15.0% | 12.8% |
| Cash | $5.1B | $4.7M |
|---|---|---|
| Total debt | $21.6B | $7.5M |
| Net debt / EBITDA | 2.0 | -0.2 |
| Interest cover | 6.3× | – |
| Dividend yield | 1.7% | – |
|---|---|---|
| Dividend per share, 12 months | $1.56 | – |
| Dividend growth a year, past | – | – |
| Buyback yield | 1.9% | – |
| Shareholder yield | 3.6% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, CRH ($62.3B) is about 3,328.2 times Rectitude ($19M), at today's prices.
Since November 12, 2025, CRH's price moved -17.8% and RECT's -40.3%. With dividends: CRH -16.6% (-16.6% a year), RECT -35.6% (-35.6% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.67% for CRH and none for Rectitude. Over the last twelve months they paid $1.56 and – per share.
At today's price, the P/E is 17.5 for CRH and 6.7 for RECT. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 9.2% for CRH and 7.0% for Rectitude, and the operating margin 13.7% and 8.3%. Revenue was $39.0B and $40M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.